XML 18 R4.htm IDEA: XBRL DOCUMENT v3.23.1Close
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 407 $ 430
Funds deposited by counterparties 330 1,708
Restricted cash 32 40
Accounts receivable, net 3,519 4,773
Inventory 722 751
Derivative instruments 4,400 7,886
Cash collateral paid in support of energy risk management activities 293 260
Prepayments and other current assets 505 383
Total current assets 10,208 16,231
Property, plant and equipment, net 1,835 1,692
Other Assets    
Equity investments in affiliates 136 133
Operating lease right-of-use assets, net 247 225
Goodwill 5,343 1,650
Intangible assets, net 4,419 2,132
Nuclear decommissioning trust fund 879 838
Derivative instruments 3,350 4,108
Deferred income taxes 2,925 1,881
Other non-current assets 354 256
Total other assets 17,653 11,223
Total Assets 29,696 29,146 Close
Current Liabilities    
Current portion of long-term debt and finance leases 971 63
Current portion of operating lease liabilities 94 83
Accounts payable 2,330 3,643
Derivative instruments 4,350 6,195
Cash collateral received in support of energy risk management activities 330 1,708
Deferred revenue current 688 176
Accrued expenses and other current liabilities 1,563 1,114
Total current liabilities 10,326 12,982
Other Liabilities    
Long-term debt and finance leases 11,332 7,976
Non-current operating lease liabilities 196 180
Nuclear decommissioning reserve 344 340
Nuclear decommissioning trust liability 514 477
Derivative instruments 1,893 2,246
Deferred income taxes 133 134
Deferred revenue non-current 848 10
Other non-current liabilities 1,030 973
Total other liabilities 16,290 12,336
Total Liabilities 26,616 25,318 Close
Commitments and Contingencies
Stockholders' Equity    
Preferred stock; 10,000,000 shares authorized; 650,000 Series A shares issued and outstanding at March 31, 2023 (liquidation preference $1,000); 0 shares issued and outstanding at December 31, 2022 650 0
Common stock; $0.01 par value; 500,000,000 shares authorized; 424,292,409 and 423,897,001 shares issued and 229,956,438 and 229,561,030 shares outstanding at March 31, 2023 and December 31, 2022, respectively 4 4
Additional paid-in-capital 8,481 8,457
(Accumulated deficit)/Retained earnings (15) 1,408
Treasury stock, at cost 194,335,971 shares at March 31, 2023 and December 31, 2022 (5,864) (5,864)
Accumulated other comprehensive loss (176) (177)
Total Stockholders' Equity 3,080 3,828 Close
Total Liabilities and Stockholders' Equity $ 29,696 $ 29,146